Frontlight ResearchEarly access
WithdrawnNo phase
Evaluation of Neurosteer System in Stroke Patients
Key facts
- Who runs it
- Neurosteer Ltd.
- Where
- Israel1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Withdrawn
- Started
- 1 Jan 2023
- Ended
- 31 Dec 2023
- Type of study
- Observational
- Treatments tested
- Neurosteer EEG recorder
- Record updated
- 8 March 2024
- Why it stopped
- No patients were recruited by the hospital staff
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Men and women over the age of 18
- Hospitalized in Soroka University Medical Center (SUMC) Neurology department with a diagnosis of Stroke
- NIHSS score ≥6
Who cannot take part
- Damage to integrity of scalp and/or skull
- Any verbal or non-verbal form of objection from patient
- Any verbal or non-verbal form of objection from patient's family member or significant other
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This is an observational study. Patients who fulfill all inclusion criteria and none of the exclusion criteria will be enrolled in the study, be neurologically evaluated and will go through a series of EEG recordings during their hospitalization. EEG recordings will be analyzed using proprietary computational analyses.
The group in the trial
- Patients
Patients who are hospitalized in Soroka University Medical Center (SUMC) Neurology department with a diagnosis of acute stroke
Treatment: Neurosteer EEG recorder
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Evaluation of Neurosteer System (Quantitative EEG Features) in Stroke Patients Suffering From Disorders of Consciousness
- Record updated
- 8 March 2024